Teva Tp Present 25-year Safety And Tolerability Data From Longest Continuous Trial Of COPAXONE For Treatment Of Relapsing Forms Of Multiple Sclerosis At 2018 ECTRIMS Annual Meeting in Berlin
Benzinga_Newsdesk